Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | -1.64% | +12.50% | +218.58% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+218.58% | 331M | |
+32.36% | 694B | |
+29.64% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.53% | 239B | |
-3.44% | 209B | |
+10.04% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Jefferies Upgrades Nektar Therapeutics to Hold From Underperform, Adjusts Price Target to $1 From $1.50